Annual Working Capital
$164.44 M
-$119.81 M-42.15%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual working capital is $164.44 million, with the most recent change of -$119.81 million (-42.15%) on December 31, 2023.
- During the last 3 years, KPTI annual working capital has fallen by -$51.89 million (-23.98%).
- KPTI annual working capital is now -42.84% below its all-time high of $287.71 million, reached on December 31, 2018.
Performance
KPTI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$123.26 M
-$27.66 M-18.33%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly working capital is $123.26 million, with the most recent change of -$27.66 million (-18.33%) on September 30, 2024.
- Over the past year, KPTI quarterly working capital has dropped by -$27.66 million (-18.33%).
- KPTI quarterly working capital is now -61.63% below its all-time high of $321.22 million, reached on March 31, 2020.
Performance
KPTI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
KPTI Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.1% | -18.3% |
| 3 y3 years | -24.0% | -28.6% |
| 5 y5 years | -42.8% | -49.0% |
KPTI Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.1% | at low | -56.6% | at low |
| 5 y | 5-year | -42.1% | at low | -61.6% | at low |
| alltime | all time | -42.8% | >+9999.0% | -61.6% | >+9999.0% |
Karyopharm Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $123.26 M(-18.3%) |
| Jun 2024 | - | $150.92 M(+13.5%) |
| Mar 2024 | - | $133.03 M(-19.1%) |
| Dec 2023 | $164.44 M(-42.1%) | $164.44 M(-18.2%) |
| Sep 2023 | - | $201.14 M(-13.5%) |
| Jun 2023 | - | $232.45 M(-9.5%) |
| Mar 2023 | - | $256.99 M(-9.6%) |
| Dec 2022 | $284.25 M(+40.8%) | $284.25 M(+76.6%) |
| Sep 2022 | - | $160.92 M(-10.6%) |
| Jun 2022 | - | $179.91 M(-14.4%) |
| Mar 2022 | - | $210.20 M(+4.1%) |
| Dec 2021 | $201.89 M(-6.7%) | $201.89 M(+16.9%) |
| Sep 2021 | - | $172.71 M(-19.8%) |
| Jun 2021 | - | $215.38 M(+11.3%) |
| Mar 2021 | - | $193.50 M(-10.6%) |
| Dec 2020 | $216.33 M(-6.8%) | $216.33 M(-7.1%) |
| Sep 2020 | - | $232.82 M(-12.9%) |
| Jun 2020 | - | $267.27 M(-16.8%) |
| Mar 2020 | - | $321.22 M(+38.3%) |
| Dec 2019 | $232.22 M(-19.3%) | $232.22 M(-3.9%) |
| Sep 2019 | - | $241.66 M(+26.8%) |
| Jun 2019 | - | $190.66 M(-16.2%) |
| Mar 2019 | - | $227.57 M(-20.9%) |
| Dec 2018 | $287.71 M | $287.71 M(+69.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $170.00 M(-18.3%) |
| Jun 2018 | - | $208.01 M(+140.3%) |
| Mar 2018 | - | $86.58 M(-12.5%) |
| Dec 2017 | $98.96 M(-14.1%) | $98.96 M(-1.6%) |
| Sep 2017 | - | $100.53 M(-21.6%) |
| Jun 2017 | - | $128.20 M(+32.5%) |
| Mar 2017 | - | $96.75 M(-16.0%) |
| Dec 2016 | $115.16 M(-29.1%) | $115.16 M(-0.1%) |
| Sep 2016 | - | $115.30 M(+6.1%) |
| Jun 2016 | - | $108.68 M(-13.0%) |
| Mar 2016 | - | $124.92 M(-23.1%) |
| Dec 2015 | $162.47 M(-16.9%) | $162.47 M(-11.7%) |
| Sep 2015 | - | $183.90 M(-12.9%) |
| Jun 2015 | - | $211.15 M(-10.0%) |
| Mar 2015 | - | $234.62 M(+20.0%) |
| Dec 2014 | $195.45 M(+26.4%) | $195.45 M(-13.2%) |
| Sep 2014 | - | $225.11 M(+73.6%) |
| Jun 2014 | - | $129.64 M(-9.1%) |
| Mar 2014 | - | $142.55 M(-7.8%) |
| Dec 2013 | $154.66 M(<-9900.0%) | $154.66 M(+211.9%) |
| Sep 2013 | - | $49.59 M(-16.9%) |
| Jun 2013 | - | $59.65 M(-6211.5%) |
| Dec 2012 | -$976.00 K(-120.6%) | -$976.00 K |
| Dec 2011 | $4.75 M | - |
FAQ
- What is Karyopharm Therapeutics annual working capital?
- What is the all time high annual working capital for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual working capital year-on-year change?
- What is Karyopharm Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly working capital year-on-year change?
What is Karyopharm Therapeutics annual working capital?
The current annual working capital of KPTI is $164.44 M
What is the all time high annual working capital for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual working capital is $287.71 M
What is Karyopharm Therapeutics annual working capital year-on-year change?
Over the past year, KPTI annual working capital has changed by -$119.81 M (-42.15%)
What is Karyopharm Therapeutics quarterly working capital?
The current quarterly working capital of KPTI is $123.26 M
What is the all time high quarterly working capital for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly working capital is $321.22 M
What is Karyopharm Therapeutics quarterly working capital year-on-year change?
Over the past year, KPTI quarterly working capital has changed by -$27.66 M (-18.33%)